IN2012DN00282A - - Google Patents

Info

Publication number
IN2012DN00282A
IN2012DN00282A IN282DEN2012A IN2012DN00282A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A IN 282DEN2012 A IN282DEN2012 A IN 282DEN2012A IN 2012DN00282 A IN2012DN00282 A IN 2012DN00282A
Authority
IN
India
Prior art keywords
breast
compositions
infants
fed infants
nutritional supplement
Prior art date
Application number
Inventor
Degonda Gabriela Bergonzelli
Isabelle Bureau-Franz
Clara Lucia Garcia-Rodenas
Corinne Magliola
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41259077&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN00282(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN00282A publication Critical patent/IN2012DN00282A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The present invention relates to a nutritional supplement compositions for breast-fed infants or pets which comprise at least one probiotic and at least one nutrient. The compositions are aimed at preserving exclusive breast feeding in infants. The compositions of the invention are also for use in improving the health of breast-fed infants. A method of preparing a nutritional supplement composition for breast-fed infants is also provided.
IN282DEN2012 2009-07-31 2010-07-28 IN2012DN00282A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09166969 2009-07-31
PCT/EP2010/060973 WO2011012655A1 (en) 2009-07-31 2010-07-28 Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients

Publications (1)

Publication Number Publication Date
IN2012DN00282A true IN2012DN00282A (en) 2015-05-08

Family

ID=41259077

Family Applications (1)

Application Number Title Priority Date Filing Date
IN282DEN2012 IN2012DN00282A (en) 2009-07-31 2010-07-28

Country Status (14)

Country Link
US (1) US20120121562A1 (en)
EP (1) EP2459202A1 (en)
CN (1) CN102481323A (en)
AU (1) AU2010277582A1 (en)
BR (1) BR112012002223A2 (en)
CA (1) CA2767960A1 (en)
CL (1) CL2012000234A1 (en)
IN (1) IN2012DN00282A (en)
MX (1) MX2012001362A (en)
RU (1) RU2012107695A (en)
SG (1) SG177541A1 (en)
TW (1) TW201117818A (en)
WO (1) WO2011012655A1 (en)
ZA (1) ZA201201471B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103384525A (en) 2010-12-31 2013-11-06 雅培制药有限公司 Human milk oligosaccharides for modulating inflammation
NZ612504A (en) 2010-12-31 2015-02-27 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
MY192208A (en) 2010-12-31 2022-08-08 Abbott Lab Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
WO2012092153A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
WO2012092154A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
CN103402376A (en) 2010-12-31 2013-11-20 雅培制药有限公司 Human milk oligosaccharides to promote growth of beneficial bacteria
CA2822219C (en) 2010-12-31 2020-12-29 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
CN102106463B (en) * 2011-01-31 2012-12-05 杨永浩 Microbial feed additives and preparation method thereof
AU2012215042B2 (en) * 2011-02-10 2016-01-14 Société des Produits Nestlé S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
ITMI20111488A1 (en) * 2011-08-03 2013-02-04 Gnosis Spa FORMULATIONS INCLUDING SACCHAROMYCES BOULARDII AND SUPEROXIDE DISMUTASIS (SOD) TO CONTROL OBESITY
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
US20140271562A1 (en) * 2011-10-18 2014-09-18 Nestec S.A. Composition for use in brain growth and/or cognitive and/or psychomotor development
EP2768311B1 (en) 2011-10-18 2018-02-21 Nestec S.A. Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
KR101166798B1 (en) * 2011-12-19 2012-07-26 김대현 Pharmaceutical compositions for treating or preventing allergic diseases comprising dead cells of lactobacillus acidoohilus lb
UA118339C2 (en) * 2012-09-03 2019-01-10 Біогайа Аб A method for selection of agents influencing intestinal motility disorders and pain
US9987306B2 (en) 2012-10-15 2018-06-05 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
WO2015148384A1 (en) 2014-03-26 2015-10-01 Abbott Laboratories Nutritional supplement powder
WO2015176229A1 (en) * 2014-05-20 2015-11-26 Nestle (China) Ltd. Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them
MX2017010923A (en) * 2015-03-05 2018-01-16 Nestec Sa Compositions for use in improving stool consistency or frequency in infants or young children.
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
CN105030843A (en) * 2015-06-18 2015-11-11 陈英扬 Lactobacillus reuteri drops and method for preparing same
AU2016315268B2 (en) * 2015-08-31 2022-12-22 Société des Produits Nestlé S.A. Methods and compositions using Bifidobacterium longum to modulate emotional reactivity and treat or prevent sub-clinical mood disturbances
MX2018006291A (en) 2015-12-14 2018-08-16 Nestec Sa Compositions and their use.
US11564667B2 (en) 2015-12-28 2023-01-31 New York University Device and method of restoring microbiota of newborns
WO2017151540A1 (en) 2016-02-29 2017-09-08 Abbott Laboratories Nutritional supplement powder
KR101938865B1 (en) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 Composition for preventing or treating bone disease, obesity and lipid-related metabolic disease
AU2018274637A1 (en) * 2017-05-24 2019-09-26 Societe Des Produits Nestle S.A. Composition comprising oligofructose (OF) for use in the improvement of short term memory and other cognitive benefits
CN110831608A (en) * 2017-06-30 2020-02-21 N·V·努特里奇亚 Synbiotic composition for preventing diseases
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S Synthetic composition for reducing allergy symptoms
CN108823125A (en) * 2018-06-13 2018-11-16 山东巴元生物科技有限公司 A kind of production method and application for treating sleep disturbance probiotics preparation
US20210298328A1 (en) * 2018-08-08 2021-09-30 Mars, Incoroprated Pet food products comprising oligosaccharides and methods of use
EP3897678A1 (en) * 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
CN113423288A (en) * 2019-02-04 2021-09-21 N·V·努特里奇亚 Fermented formula containing non-digestible oligosaccharides for sleep improvement
KR102188765B1 (en) * 2019-06-12 2020-12-08 정옥숙 Freeze-dried powder for pet and manufacturing method thereof
CN112868800A (en) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 Infant formula milk powder containing breast milk oligosaccharide for improving immunity and preparation method thereof
EP4065146A1 (en) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936799C1 (en) * 1989-11-04 1991-01-10 Deutsche Atochem Werke Gmbh, 5300 Bonn, De
FR2714574B1 (en) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa New food supplements for the nutrition of very young children.
EP1429620A1 (en) * 2001-08-31 2004-06-23 Nutricopia, Inc. Nutritional frozen dessert and methods of menufacture
PT1638415E (en) * 2003-06-23 2011-01-10 Nestec Sa Infant or follow-on formula
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
CA2542612A1 (en) * 2003-10-14 2005-04-21 Kingston Henry Gordon Mills Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP2805625B2 (en) * 2005-02-28 2022-11-23 N.V. Nutricia Nutritional composition with prebiotics and probiotics
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US20070059297A1 (en) * 2005-08-04 2007-03-15 Nestec, S.A. Methods and compositions for improving visual acuity
EP1940248B1 (en) * 2005-10-05 2009-12-16 Nestec S.A. Use of a nutritional formulation for promoting catch-up growth
RU2428055C2 (en) * 2006-03-29 2011-09-10 Нестек С.А. Biologically active supplement containing probiotic, fodder composition containing this supplement and fodder composition production method, set and method for administration of probiotics to animal, animal health condition stimulation method (versions)
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
NL1033521C2 (en) * 2007-03-08 2008-09-09 Friesland Brands Bv Children's foods with optimized amino acid composition.
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
RU2010129825A (en) * 2007-12-17 2012-01-27 Юриверсити Оф Флорида Рисерч Фаундейшн, Инк. (Us) MATERIALS AND METHODS FOR TREATMENT OF PATHOLOGICAL PROLIFERATION OF EYE VESSELS
JP5882735B2 (en) * 2008-09-19 2016-03-09 ネステク ソシエテ アノニム Nutritional support to prevent or alleviate bone marrow paralysis or neutropenia during anticancer treatment

Also Published As

Publication number Publication date
WO2011012655A1 (en) 2011-02-03
CN102481323A (en) 2012-05-30
AU2010277582A1 (en) 2012-02-02
US20120121562A1 (en) 2012-05-17
ZA201201471B (en) 2014-08-27
CL2012000234A1 (en) 2012-09-28
BR112012002223A2 (en) 2016-06-07
TW201117818A (en) 2011-06-01
CA2767960A1 (en) 2011-02-03
EP2459202A1 (en) 2012-06-06
SG177541A1 (en) 2012-02-28
MX2012001362A (en) 2012-02-22
RU2012107695A (en) 2013-09-10

Similar Documents

Publication Publication Date Title
IN2012DN00282A (en)
MY164674A (en) Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
MX2022004262A (en) Methods and compositions for enhancing health.
PH12017502350A1 (en) Nutritional compositions with 2fl and lnnt for use in inducing a gut microbiota close to the one of breast fed infants
MY173382A (en) Infant feeding formulas comprising probiotic micro-organisms
MX2013005338A (en) Array of age-tailored nutritional formula with probiotics.
IN2012DN00713A (en)
IN2014CN04773A (en)
MY161548A (en) Nutritional supplements for 50+individuals for improving vitality, immunity, eye and bone health
MX2015015628A (en) Tall oil fatty acid for use in treatment and animal feed supplements and compositions.
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
MX2013005406A (en) Age-tailored nutritional composition with animal fats and vegetable fats.
MY175195A (en) Nutritional compositions
MX2013012136A (en) Compositions comprising a glucose anti-metabolite and selenium.
SG149718A1 (en) Cordyceps extract as a dietary supplement and uses thereof
MY174494A (en) Method for inhibiting pathogens using a nutritional composition
PH12018500988A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
MX346623B (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof.
PH12018500953A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PH12018500924A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
PT2477503E (en) Process for preparing a pasteurised and fermented dairy product supplemented with calcium and vitamin d
PH12018500890A1 (en) Nutritional compositions and infant formulas to promote myelination in the brain
MX2018006296A (en) Nutritional compositions and infant formulas to promote myelination in the brain.
MX2018006290A (en) Nutritional compositions and infant formulas to promote myelination in the brain.
CN105454817A (en) Calcium supplement food